Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1993 1
1994 1
1995 1
1996 1
1997 3
2000 2
2002 2
2003 2
2004 1
2005 4
2006 6
2007 9
2008 6
2009 6
2010 7
2011 4
2012 7
2013 6
2014 4
2015 3
2016 3
2017 5
2018 7
2019 4
2020 6
2021 8
2022 9
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Effect of DMARDs on the immunogenicity of vaccines.
van Sleen Y, van der Geest KSM, Huckriede ALW, van Baarle D, Brouwer E. van Sleen Y, et al. Among authors: huckriede alw. Nat Rev Rheumatol. 2023 Sep;19(9):560-575. doi: 10.1038/s41584-023-00992-8. Epub 2023 Jul 12. Nat Rev Rheumatol. 2023. PMID: 37438402 Review.
Needle-free influenza vaccination.
Amorij JP, Hinrichs WLj, Frijlink HW, Wilschut JC, Huckriede A. Amorij JP, et al. Among authors: huckriede a. Lancet Infect Dis. 2010 Oct;10(10):699-711. doi: 10.1016/S1473-3099(10)70157-2. Lancet Infect Dis. 2010. PMID: 20883966 Review.
Development of an inhalable antiviral powder formulation against respiratory syncytial virus.
Heida R, Akkerman R, Jacob Silva PH, Lakerveld AJ, Ortiz D, Bigogno C, Gasbarri M, van Kasteren PB, Stellacci F, Frijlink HW, Huckriede ALW, Hinrichs WLJ. Heida R, et al. Among authors: huckriede alw. J Control Release. 2023 May;357:264-273. doi: 10.1016/j.jconrel.2023.03.059. Epub 2023 Apr 5. J Control Release. 2023. PMID: 37015293 Free article.
Advances in the development of entry inhibitors for sialic-acid-targeting viruses.
Heida R, Bhide YC, Gasbarri M, Kocabiyik Ö, Stellacci F, Huckriede ALW, Hinrichs WLJ, Frijlink HW. Heida R, et al. Among authors: huckriede alw. Drug Discov Today. 2021 Jan;26(1):122-137. doi: 10.1016/j.drudis.2020.10.009. Epub 2020 Oct 21. Drug Discov Today. 2021. PMID: 33099021 Free PMC article. Review.
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
Tan NH, Geers D, Sablerolles RSG, Rietdijk WJR, Goorhuis A, Postma DF, Visser LG, Bogers S, van Dijk LLA, Gommers L, van Leeuwen LPM, Boerma A, Nijhof SH, van Dort KA, Koopmans MPG, Dalm VASH, Lafeber M, Kootstra NA, Huckriede ALW, van Baarle D, Zaeck LM, GeurtsvanKessel CH, de Vries RD, van der Kuy PHM; SWITCH ON Research Group. Tan NH, et al. Among authors: huckriede alw. Lancet Infect Dis. 2023 Aug;23(8):901-913. doi: 10.1016/S1473-3099(23)00140-8. Epub 2023 Apr 21. Lancet Infect Dis. 2023. PMID: 37088096 Free PMC article. Clinical Trial.
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
Sablerolles RSG, Rietdijk WJR, Goorhuis A, Postma DF, Visser LG, Geers D, Schmitz KS, Garcia Garrido HM, Koopmans MPG, Dalm VASH, Kootstra NA, Huckriede ALW, Lafeber M, van Baarle D, GeurtsvanKessel CH, de Vries RD, van der Kuy PHM; SWITCH Research Group. Sablerolles RSG, et al. Among authors: huckriede alw. N Engl J Med. 2022 Mar 10;386(10):951-963. doi: 10.1056/NEJMoa2116747. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045226 Free PMC article. Clinical Trial.
Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
Murugappan S, Patil HP, Kanojia G, ter Veer W, Meijerhof T, Frijlink HW, Huckriede A, Hinrichs WL. Murugappan S, et al. Among authors: huckriede a. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):716-25. doi: 10.1016/j.ejpb.2013.07.018. Epub 2013 Aug 8. Eur J Pharm Biopharm. 2013. PMID: 23933147
The virosome concept for influenza vaccines.
Huckriede A, Bungener L, Stegmann T, Daemen T, Medema J, Palache AM, Wilschut J. Huckriede A, et al. Vaccine. 2005 Jul 8;23 Suppl 1:S26-38. doi: 10.1016/j.vaccine.2005.04.026. Vaccine. 2005. PMID: 16026906 Review.
[A preview of COVID-19 vaccination and treatment].
de Boer MGJ, Bonten MJM, Huckriede ALW. de Boer MGJ, et al. Among authors: huckriede alw. Ned Tijdschr Geneeskd. 2022 May 12;166:D6880. Ned Tijdschr Geneeskd. 2022. PMID: 36036707 Dutch.
117 results